Thursday midday is delivering some high-art corporate comedy.
Look at $PPCB (+134%). A micro-cap biotech with a tiny $3 million market capitalization has proudly authorized a $5 million share repurchase program. Shuffling $5 million to buy back a $3 million company is a fascinating treasury strategy. Elsewhere, $GELS (+146%) and $GLXG (+137%) are vertical on absolute silence—no news, just the usual low-float momentum chasers passing a hot potato.
Across the ticker, $ADTX slides 25% after separating its oncology unit into a new company. For a stock sporting a microscopic $23,000 market cap, rearranging the deck chairs won't stop the ship from taking on water.
Take a walk, order some food, and let the retail chasers fund the market maker's summer home.